Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1987 1
1988 3
1990 2
1991 1
1992 1
1993 4
1994 1
1995 6
1996 4
1997 1
1998 1
1999 3
2000 4
2001 7
2002 16
2003 8
2004 6
2005 8
2006 5
2007 10
2008 7
2009 7
2010 5
2011 8
2012 6
2013 11
2014 13
2015 27
2016 8
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

175 results

Results by year

Filters applied: . Clear all
Page 1
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer.
Ramus SJ, Song H, Dicks E, Tyrer JP, Rosenthal AN, Intermaggio MP, Fraser L, Gentry-Maharaj A, Hayward J, Philpott S, Anderson C, Edlund CK, Conti D, Harrington P, Barrowdale D, Bowtell DD, Alsop K, Mitchell G; AOCS Study Group; Cicek MS, Cunningham JM, Fridley BL, Alsop J, Jimenez-Linan M, Poblete S, Lele S, Sucheston-Campbell L, Moysich KB, Sieh W, McGuire V, Lester J, Bogdanova N, Dürst M, Hillemanns P; Ovarian Cancer Association Consortium; Odunsi K, Whittemore AS, Karlan BY, Dörk T, Goode EL, Menon U, Jacobs IJ, Antoniou AC, Pharoah PD, Gayther SA. Ramus SJ, et al. J Natl Cancer Inst. 2015 Aug 27;107(11):djv214. doi: 10.1093/jnci/djv214. Print 2015 Nov. J Natl Cancer Inst. 2015. PMID: 26315354 Free PMC article.
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors.
Eckel-Passow JE, Lachance DH, Molinaro AM, Walsh KM, Decker PA, Sicotte H, Pekmezci M, Rice T, Kosel ML, Smirnov IV, Sarkar G, Caron AA, Kollmeyer TM, Praska CE, Chada AR, Halder C, Hansen HM, McCoy LS, Bracci PM, Marshall R, Zheng S, Reis GF, Pico AR, O'Neill BP, Buckner JC, Giannini C, Huse JT, Perry A, Tihan T, Berger MS, Chang SM, Prados MD, Wiemels J, Wiencke JK, Wrensch MR, Jenkins RB. Eckel-Passow JE, et al. N Engl J Med. 2015 Jun 25;372(26):2499-508. doi: 10.1056/NEJMoa1407279. Epub 2015 Jun 10. N Engl J Med. 2015. PMID: 26061753 Free PMC article.
Transition rates between amyloid and neurodegeneration biomarker states and to dementia: a population-based, longitudinal cohort study.
Jack CR Jr, Therneau TM, Wiste HJ, Weigand SD, Knopman DS, Lowe VJ, Mielke MM, Vemuri P, Roberts RO, Machulda MM, Senjem ML, Gunter JL, Rocca WA, Petersen RC. Jack CR Jr, et al. Lancet Neurol. 2016 Jan;15(1):56-64. doi: 10.1016/S1474-4422(15)00323-3. Epub 2015 Nov 18. Lancet Neurol. 2016. PMID: 26597325 Free PMC article.
Hodgkin's disease.
Windebank KP, Gilchrist GS. Windebank KP, et al. Pediatr Ann. 1988 Mar;17(3):204-17, 220-3. doi: 10.3928/0090-4481-19880301-09. Pediatr Ann. 1988. PMID: 3281106 Review. No abstract available.
Novel therapeutics in colorectal cancer.
McWilliams RR, Erlichman C. McWilliams RR, et al. Dis Colon Rectum. 2005 Aug;48(8):1632-50. doi: 10.1007/s10350-005-0026-8. Dis Colon Rectum. 2005. PMID: 15906130 Review.
Complications of myeloma therapy.
Dispenzieri A. Dispenzieri A. Hematol Oncol Clin North Am. 2007 Dec;21(6):1247-73, xi. doi: 10.1016/j.hoc.2007.08.002. Hematol Oncol Clin North Am. 2007. PMID: 17996597 Review.
175 results